Personnelle Leg relief
Natural health product licensed in Canada
- Other names
- BIOMEDIC SOULAGEMENT POUR LES JAMBES 360MG, Dr Nutrition 360 Leg Relief, Life Brand Leg relief, MapleLife Nutrition Leg relief, Personnelle Soulagement pour les jambes, Puravita Leg relief Tablet
- Licence holder
- Nutralab Canada Corp.
- NPN or DIN-HM
- 80076298
- Status
- Active licence
- Licence date
- 23 March 2017
- Revision date
- 11 July 2023
- Form
- Comprimé, enrobé par pellicule
- Route of administration
- Orale
- Application type
- Non traditionnelle
If this product were sold in France
No point flagged by the rules we apply.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Vitis vinifera var. tinctoria Source : Feuille Extract : Matériel brut sec Extraction ratio : 4:1 Dry plant equivalent : 1,440 milligramme | 360 milligramme | Not calculated |
Non-medicinal ingredients
Glycolate d'amidon sodique, Poly(éthylène glycol), Cellulose microcristalline, Eau purifiée, Phosphate de calcium, dibasique, anhydre, Talc, Stéarate de magnésium, Hypromellose, Dioxyde de silicium, Oxyde de fer (Fe2O3)
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | Not specified | minimum: 1 Comprimé ; maximum: 2 Comprimé | 1 Tous les jours |
Uses authorised in Canada
Text supplied in English because no French text is available.
Helps to reduce lower leg oedema associated with mild-to-moderate chronic venous insufficiency. Helps to relieve symptoms of mild-to-moderate chronic venous insufficiency, such as tired, heavy, sensation of tension or tingling, and pain in legs.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
- Précautions et mises en garde
If you suffer, or experience, inflammation of the skin, thrombophlebitis or subcutaneous induration, severe pain, ulcers, sudden swelling of one or both legs, cardiac or renal insufficiency or disorder, consult a health care practitioner prior to use. Consult a health care practitioner prior to use if you are pregnant or breastfeeding. Hypersensitivity/allergy (e.g., skin itching, redness, and rash) has been known to occur; in which case, discontinue use. Nausea, gastrointestinal disturbances, and headache may occur. If symptoms persist, worsen, or if new symptoms appear, discontinue use and consult a health care practitioner.
Source
Official Health Canada record, licence 80076298
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
List in the official revision dated (register: Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks).
List recorded in 2023. Photograph the packaging to check whether it has changed. Photograph the packaging